Most Read Articles
4 days ago
Supplementation with probiotics may have positive effects in patients with type 2 diabetes mellitus (T2DM), reports a recent meta-analysis.
Pearl Toh, 09 Mar 2020
A combination therapy of enfortumab vedotin and pembrolizumab shows promising activity, with rapid and durable responses in the first-line setting for patients with metastatic urothelial carcinoma (mUC) ineligible to receive cisplatin, according to updates from the EV-103* study presented at GUCS 2020.
2 days ago
The most accurate intraocular lens (IOL) power formula for patients with keratoconus is the modified Kane formula, while the SRK/T outdoes other traditional IOL power formulas, according to the results of a recent study.
Christina Lau, 14 Jul 2020

Flat-dose nivolumab, administered as a 30-minute infusion, is well tolerated and active in Asian patients with previously treated advanced non-small-cell lung cancer (NSCLC), according to results of the phase IIIb CheckMate 870 study.

Keeping up to date in primary care: Insights from IMPACT

16 Jul 2020
Updated health information is crucial for healthcare professionals to improve their knowledge in providing healthcare services. During a series of talks at the IMPACT GP Symposium 2020 held in Singapore on 11 January 2020, a panel of specialists shared insights on current treatment approaches for atopic dermatitis and wound healing, as well as updates from the 2019 dyslipidaemia guidelines and on the management of fatty liver disease.
Editor's Recommendations
Most Read Articles
4 days ago
Supplementation with probiotics may have positive effects in patients with type 2 diabetes mellitus (T2DM), reports a recent meta-analysis.
Pearl Toh, 09 Mar 2020
A combination therapy of enfortumab vedotin and pembrolizumab shows promising activity, with rapid and durable responses in the first-line setting for patients with metastatic urothelial carcinoma (mUC) ineligible to receive cisplatin, according to updates from the EV-103* study presented at GUCS 2020.
2 days ago
The most accurate intraocular lens (IOL) power formula for patients with keratoconus is the modified Kane formula, while the SRK/T outdoes other traditional IOL power formulas, according to the results of a recent study.
Christina Lau, 14 Jul 2020

Flat-dose nivolumab, administered as a 30-minute infusion, is well tolerated and active in Asian patients with previously treated advanced non-small-cell lung cancer (NSCLC), according to results of the phase IIIb CheckMate 870 study.